Choose your concern
Explore the condition guides and available assessment options.
Care365 medication guide
Supports weight management in eligible patients.
Uses, directions and safety information for Liraglutide (Saxenda).
Supports weight management in eligible patients.
Usually begins at 0.6 mg daily, increasing by 0.6 mg at weekly intervals toward 3 mg. Tolerance and response require review.
Avoid relevant allergy, medullary thyroid cancer history or MEN 2. Do not combine with another liraglutide product.
Nausea, vomiting, diarrhoea and constipation.
Severe persistent abdominal pain, dehydration or repeated vomiting needs assessment.
Review insulin, sulfonylureas and other medicines.
Avoid pregnancy and discuss plans to conceive or breastfeed before use.
Follow your own product’s missed-dose instructions. If you are unsure, ask a pharmacist before taking an extra dose. Contraceptives, injections and modified-release medicines may need a specific plan.
Keep the original packaging and follow its storage, expiry and disposal instructions. Keep medicines away from children and pets. Ask about refrigeration, after-opening limits and safe sharps disposal when relevant.
For suspected overdose or accidental swallowing, contact poison control or urgent medical care promptly. Call emergency services for breathing difficulty, collapse or a seizure.
Care that starts with a conversation
Explore care for your symptoms and prepare for a conversation about treatment. Your healthcare professional will consider your history, current medicines and whether an assessment or referral is appropriate.
Know what to prepare and what to discuss.
Explore the condition guides and available assessment options.
Prepare your symptoms, allergies, medication list and treatment questions.
A healthcare professional assesses which care or referral is appropriate.
Follow the advice you receive about treatment, monitoring and next steps.
For a review of Liraglutide (Saxenda), have your current dose, reason for treatment, remaining supply, benefits, side effects and pharmacy details ready. Ask your pharmacist or prescriber whether a renewal assessment is available and appropriate. A prescription or renewal is not guaranteed.
Supports weight management in eligible patients.
Usually begins at 0.6 mg daily, increasing by 0.6 mg at weekly intervals toward 3 mg. Tolerance and response require review.
Nausea, vomiting, diarrhoea and constipation.
Severe persistent abdominal pain, dehydration or repeated vomiting needs assessment.
Review insulin, sulfonylureas and other medicines.
Avoid pregnancy and discuss plans to conceive or breastfeed before use.
Sources checked 2026-09-08. Safety sections are highlights; consult the full product information for complete warnings and instructions.
Check the Canadian Drug Product Database by product name or DIN for current product information.
← Browse all medication guides